BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song C, Yu D, Wang Y, Wang Q, Guo Z, Huang J, Li S, Hu W. Dual Primary Cancer Patients With Lung Cancer as a Second Primary Malignancy: A Population-Based Study. Front Oncol 2020;10:515606. [PMID: 33194578 DOI: 10.3389/fonc.2020.515606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Xue F, Niu X, Hu C, He X. Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma. Front Oncol 2022;12:801090. [PMID: 35280823 DOI: 10.3389/fonc.2022.801090] [Reference Citation Analysis]
2 Zhu J, Shi H, Ran H, Lai Q, Shao Y, Wu Q. Development and Validation of a Nomogram for Predicting Overall Survival in Patients with Second Primary Small Cell Lung Cancer After Non-Small Cell Lung Cancer: A SEER-Based Study. IJGM 2022;Volume 15:3613-24. [DOI: 10.2147/ijgm.s353045] [Reference Citation Analysis]
3 Doroudian M, Azhdari MH, Goodarzi N, O'Sullivan D, Donnelly SC. Smart Nanotherapeutics and Lung Cancer. Pharmaceutics 2021;13:1972. [PMID: 34834387 DOI: 10.3390/pharmaceutics13111972] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen B, Zeng Y, Liu B, Lu G, Xiang Z, Chen J, Yu Y, Zuo Z, Lin Y, Ma J. Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study. Front Endocrinol (Lausanne) 2021;12:672024. [PMID: 34393996 DOI: 10.3389/fendo.2021.672024] [Reference Citation Analysis]
5 Ebia MI, Capone S, Ricker C, Thomas JS, Tulpule V, Kang I, D'Souza A, Freyer DR, Miller K, In GK. A Case Series of Multiple Primary Malignancies Among Patients With Advanced Melanoma. Cureus 2021;13:e15480. [PMID: 34262818 DOI: 10.7759/cureus.15480] [Reference Citation Analysis]